News Focus
News Focus
Followers 55
Posts 4222
Boards Moderated 0
Alias Born 03/20/2014

Re: None

Monday, 07/29/2024 12:13:20 PM

Monday, July 29, 2024 12:13:20 PM

Post# of 517022
Having seen the data the EMA is positive towards Anavex, requesting it ask for Full Approval for Alzheimer's Disease.

Without pushing it too far I wonder if Anavex needs to dot every i and cross every T? They have a hungry willing market begging for what they have. Would it be foolish to assume the EMA would like to have something in front of them they can approve? And won't be scrutinizing minutia with artificial intelligence?

Would it be foolish to assume some at the EMA would also like to start taking 30mg of Blarcamesine before year end?

I don't know how these things go but I don't think Anavex needs to ask for any favors to expect Blarcamesine to be approved.

Does Anavex need to include the OLE data?

All my posts are my opinion only and shouldn’t be used for decisions regarding purchasing or selling.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News